Condition
Helicobacter Pylori Infection, Susceptibility to
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07293169Not Yet RecruitingPrimary
Helicobacter Pylori Infection Among Women With Recurrent Abortion of Unknown Cause
NCT05410652Completed
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
NCT05863858Phase 3Completed
Eradication of H. Pylori Infection With Moxifloxacin
NCT05247112Recruiting
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Showing all 4 trials